The Bernese method is a specific, published protocol for low-dose buprenorphine induction, originally developed in Switzerland (Bern) and increasingly referenced in U.S. clinical practice as fentanyl has changed the induction landscape.
What makes it a specific “method” rather than a general concept
Unlike the broader idea of low-dose induction [link], the Bernese method refers to a specific published dosing protocol with defined steps and timing, giving prescribers a concrete, studied framework to follow rather than an improvised approach.
The general shape of the approach
It involves starting with very small buprenorphine doses, increasing gradually over roughly a week, while the person continues their usual opioid briefly at the start — with the goal of reaching a full buprenorphine dose without ever triggering precipitated withdrawal along the way. The specific schedule is something your prescriber would follow directly; it’s not something to replicate from a general description.
Why this specific protocol matters
Having a named, published, studied protocol gives prescribers who are less experienced with low-dose induction a concrete reference to follow, which has likely contributed to this approach spreading faster than a purely individualized low-dose strategy might have.
What to ask a prescriber if you’re interested in this approach
Whether they’re familiar with the Bernese method or a similar published low-dose protocol specifically, rather than assuming all “micro-dosing” approaches are the same or equally studied.
Medically reviewed by [pending]. Sources: clinical literature describing the Bernese method of buprenorphine micro-induction.